These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2945785)

  • 1. Decreased calcium pump adenosine triphosphatase in red blood cells of hypertensive subjects.
    Vincenzi FF; Morris CD; Kinsel LB; Kenny M; McCarron DA
    Hypertension; 1986 Nov; 8(11):1058-66. PubMed ID: 2945785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet and erythrocyte Mg2+, Ca2+, Na+, K+ and cell membrane adenosine triphosphatase activity in essential hypertension in blacks.
    Touyz RM; Milne FJ; Reinach SG
    J Hypertens; 1992 Jun; 10(6):571-8. PubMed ID: 1320078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet membrane Ca(2+)-ATPase: blunted calmodulin-stimulation in essential hypertension.
    Resink TJ; Tkachuk VA; Erne P; Bühler FR
    J Hypertens Suppl; 1985 Dec; 3(3):S37-40. PubMed ID: 2856741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma membrane Ca2+ transport: antagonism by several potential inhibitors.
    Hinds TR; Raess BU; Vincenzi FF
    J Membr Biol; 1981 Jan; 58(1):57-65. PubMed ID: 6163856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activities of transport adenosine triphosphatases in erythrocyte membranes of healthy and hypertensive subjects.
    Lin SJ; Hong CY; Chiang BN; Wei YH
    Clin Exp Hypertens A; 1985; 7(8):1151-63. PubMed ID: 2994917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red blood cell calmodulin and Ca2+ pump ATPase: preliminary results of a species comparison.
    Vincenzi FF
    Prog Clin Biol Res; 1981; 55():363-83. PubMed ID: 6117080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Erythrocyte and plasma Ca2+, Mg2+ and cell membrane adenosine triphosphatase activity in patients with essential hypertension.
    Fu Y; Wang S; Lu Z; Li H; Li S
    Chin Med J (Engl); 1998 Feb; 111(2):147-9. PubMed ID: 10374376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte calcium-stimulated, magnesium-activated adenosine 5'-triphosphatase activity in essential hypertension.
    Adeoya AS; Bing RF; Norman RI
    J Hypertens; 1992 Jul; 10(7):651-6. PubMed ID: 1321192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet membrane calmodulin-stimulated calcium-adenosine triphosphatase. Altered activity in essential hypertension.
    Resink TJ; Tkachuk VA; Erne P; Bühler FR
    Hypertension; 1986 Feb; 8(2):159-66. PubMed ID: 2935496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trifluoperazine inhibition of calmodulin-sensitive Ca2+ -ATPase and calmodulin insensitive (Na+ +K+)- and Mg2+ -ATPase activities of human and rat red blood cells.
    Luthra MG
    Biochim Biophys Acta; 1982 Nov; 692(2):271-7. PubMed ID: 6128998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of long-chain fatty acids in vitro on Ca2+-stimulatable, Mg2+-dependent ATPase activity in human red cell membranes.
    Davis FB; Davis PJ; Blas SD; Schoenl M
    Biochem J; 1987 Dec; 248(2):511-6. PubMed ID: 2963620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calmodulin-stimulated plasma membrane (Ca2+ + Mg2+)-ATPase: inhibition by calcium channel entry blockers.
    Raess BU; Gersten MH
    Biochem Pharmacol; 1987 Aug; 36(15):2455-9. PubMed ID: 3038124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of basal and calmodulin-activated Ca2+-pump ATPase by fractionated compound 48/80.
    Di Julio D; Hinds TR; Vincenzi FF
    Biochim Biophys Acta; 1989 Jun; 981(2):337-42. PubMed ID: 2525052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calmodulin and the plasma membrane calcium pump.
    Vincenzi FF; Hinds TR; Raess BU
    Ann N Y Acad Sci; 1980; 356():232-44. PubMed ID: 6112944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes of Ca2(+)-ATPase and calmodulin in erythrocytes and their responses to nifedipine in essential hypertension].
    Song K
    Zhonghua Xin Xue Guan Bing Za Zhi; 1990 Oct; 18(5):260-1, 318. PubMed ID: 2150803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The nature of the Ca2+-pump defect in the red blood cells of patients with cystic fibrosis.
    Muallem S; Miner C; Seymour CA
    Biochim Biophys Acta; 1985 Sep; 819(1):143-7. PubMed ID: 2931115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of erythrocyte membrane Ca2(+)-Mg2(+)-ATPase activity in children with and without family history of essential hypertension.
    Cheng HY; Liu LS; Zheng DY
    J Hum Hypertens; 1990 Apr; 4(2):147-8. PubMed ID: 2140135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythrocyte membrane (Ca2+ + Mg2+)-ATPase in human protein-energy malnutrition.
    Olorunsogo OO
    Biosci Rep; 1989 Jun; 9(3):359-68. PubMed ID: 2550100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Verapamil, diltiazem and nifedipine interactions with calmodulin stimulated (Ca2+ + Mg2+)-ATPase.
    Kim HC; Raess BU
    Biochem Pharmacol; 1988 Mar; 37(5):917-20. PubMed ID: 2964236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Ca pump and Ca ATPase in the erythrocytes of patients with hypertension: disorders detected in cytoskeletal membranes and in solubilized Ca ATPase].
    Pokudin NI; Orlov SN; Postnov IuV
    Kardiologiia; 1986 Mar; 26(3):94-9. PubMed ID: 2423739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.